Society for Hematopathology is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G90). Contributions are tax-deductible.
2111 Chestnut Ave Ste 145, Glenview, IL 60025-1609
Among the 4 scored disease & disorders organizations in Glenview, Society for Hematopathology holds 3.6 months of operating reserves (peer median 4.1 months), runs a typical yearly deficit of 30.0% (peers: deficit of 3.8%), and has grown spending 76.4% a year (peers: grown spending 38.0% a year).
In fiscal year 2026 it reported $590,594 in revenue and $773,571 in expenses, with contributions making up 31.5% of revenue.
Stimulate interest, research, exchange of information and dissemination of knowledge concerning the biology, diagnosis and clinical aspects of the hematopoietic and lymphoreticular systems.
Largest programs · fiscal year 2026
Provided World Health Organization restricted funds received in prior years of $276,000 plus an additional $103,532 received this year to the Unicersity of Chicago.$379,532 spent · 52.4% of program spending
Co-sponsored the 2025 SH-EAHP Workshop on the malignancies and reactive disorders encountered in children, adolescents and young adults (AYA), many of which present preferentially or exclusively in this age group. It is the first SH-EAHP workshop in 22 years to focus on the hematopathologic disorders of this patient population. A major emphasis of the Workshop was to highlight advances in our unde… Read more
Co-sponsored the 2025 SH-EAHP Workshop on the malignancies and reactive disorders encountered in children, adolescents and young adults (AYA), many of which present preferentially or exclusively in this age group. It is the first SH-EAHP workshop in 22 years to focus on the hematopathologic disorders of this patient population. A major emphasis of the Workshop was to highlight advances in our understanding of the molecular pathogenesis, particularly as they relate to the diagnosis, prognostication and clinical treatment of these disorders and the post-therapy detection of measurable residual disease using flow cytometric and next-generation sequencing-based molecular approaches. There were more than 400 attendees from approximately 30 different countries in attendance. Also participated in the USCAP meeting.
$333,793 spent · 46.1% of program spending
Maintained website for membership and interested individuals which included a "case of the quarter" as well as video tutorials and other education related materials for professionals to review. Also, includes a "Virtual Curriculum" which is a series of lectures designed to provide hematopathology educational resources to pathology trainees affected by the COVID-19 pandemic. The lectures cover rele… Read more
Maintained website for membership and interested individuals which included a "case of the quarter" as well as video tutorials and other education related materials for professionals to review. Also, includes a "Virtual Curriculum" which is a series of lectures designed to provide hematopathology educational resources to pathology trainees affected by the COVID-19 pandemic. The lectures cover relevant topics in bone marrow, lymph node and spleen pathology.
$11,174 spent · 1.5% of program spending
Where each dollar went · fiscal year 2026
Of every dollar it spent, 94¢ went to programs, 6¢ to management and 0¢ to fundraising.
Programs $724,499
Management $49,072
Fundraising $0
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
94%
Meets
Compared with Glenview peers
Measure
This organization
Peer median
Operating reserves
3.6 mo
4.1 mo
Typical margin
−30.0%
−3.8%
Spending growth
+76.4% / yr
+38.0% / yr
Debt load
0.0%
1.6%
Peers: the 4 Glenview disease & disorders organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$590,594Fiscal year 2026
Expenses$773,571Fiscal year 2026
Total assets$230,192Fiscal year 2026
Total liabilities$0Fiscal year 2026
Fiscal year ending June2026
Revenue$590,594
Expenses$773,571
Net income−$182,977
Net assets$230,192
Notable sources of revenue
Percent of total revenue
Contributions
$186,113
31.5%
Program services
$401,406
68.0%
Investment income
$0
0.0%
Other (net)
$3,075
0.5%
Assets / debt
Total assets
$230,192
Total liabilities
$0
Net assets
$230,192
Compensation
Not in our extract for this year.
Fiscal year ending June2025
Revenue$89,294
Expenses$140,146
Net income−$50,852
Net assets$413,169
Notable sources of revenue
Percent of total revenue
Contributions
$0
0.0%
Program services
$85,174
95.4%
Investment income
$0
0.0%
Other (net)
$4,120
4.6%
Assets / debt
Total assets
$554,951
Total liabilities
$141,782
Net assets
$413,169
Compensation
Not in our extract for this year.
Fiscal year ending June2024
Revenue$475,711
Expenses$409,370
Net income$66,341
Net assets$464,021
Notable sources of revenue
Percent of total revenue
Contributions
$103,195
21.7%
Program services
$359,039
75.5%
Investment income
$12,462
2.6%
Other (net)
$1,015
0.2%
Assets / debt
Total assets
$464,021
Total liabilities
$0
Net assets
$464,021
Compensation
Not in our extract for this year.
Fiscal year ending June2023
Revenue$63,636
Expenses$141,022
Net income−$77,386
Net assets$397,680
Notable sources of revenue
Percent of total revenue
Contributions
$750
1.2%
Program services
$62,886
98.8%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$516,438
Total liabilities
$118,758
Net assets
$397,680
Compensation
Officers and key employees
$0
Share of expenses
0.0%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?